Published in Sci Rep on November 06, 2014
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States. Clin Infect Dis (2015) 3.83
Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proc Natl Acad Sci U S A (2014) 1.44
Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses. Sci Rep (2016) 1.13
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies. J Virol (2015) 1.00
Ebolavirus Evolution: Past and Present. PLoS Pathog (2015) 0.97
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science (2016) 0.97
Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus. Infect Dis Poverty (2014) 0.94
Discovery of an antibody for pan-ebolavirus therapy. Sci Rep (2016) 0.93
Ebola virus disease complicated with viral interstitial pneumonia: a case report. BMC Infect Dis (2015) 0.88
Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway. MBio (2016) 0.87
Euthanasia assessment in ebola virus infected nonhuman primates. Viruses (2014) 0.85
Ebola Virus Infection: Overview and Update on Prevention and Treatment. Infect Dis Ther (2015) 0.83
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site. Cell Rep (2016) 0.83
Ebola virus entry into host cells: identifying therapeutic strategies. Curr Clin Microbiol Rep (2015) 0.82
Ebolavirus comparative genomics. FEMS Microbiol Rev (2015) 0.82
Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry. J Virol (2016) 0.81
Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection. J Infect Dis (2015) 0.81
Structures of Ebola virus GP and sGP in complex with therapeutic antibodies. Nat Microbiol (2016) 0.78
Potent neutralizing monoclonal antibodies against Ebola virus infection. Sci Rep (2016) 0.77
Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies. J Virol (2016) 0.77
Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity. EBioMedicine (2015) 0.77
Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic. Sci Rep (2016) 0.77
Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs. PLoS One (2016) 0.76
Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies. MAbs (2016) 0.75
Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection. Sci Rep (2017) 0.75
Unveiling a Drift Resistant Cryptotope within Marburgvirus Nucleoprotein Recognized by Llama Single-Domain Antibodies. Front Immunol (2017) 0.75
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature (2014) 6.94
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature (2008) 5.24
Epitopes involved in antibody-mediated protection from Ebola virus. Science (2000) 4.92
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell (1998) 4.73
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci U S A (2012) 3.35
IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res (2013) 3.33
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99
Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med (2012) 2.98
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci U S A (2012) 2.83
Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med (2013) 2.29
mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms. Sci Transl Med (2013) 2.10
Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep (2013) 2.01
IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF. Nucleic Acids Res (2009) 1.94
Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J Virol (2003) 1.78
Cloning and expression of murine Ig genes from single B cells. J Immunol Methods (2009) 1.73
Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin Immunol (2011) 1.73
Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. J Virol (2010) 1.62
Epitopia: a web-server for predicting B-cell epitopes. BMC Bioinformatics (2009) 1.55
Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLoS One (2012) 1.54
A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J Virol (2011) 1.53
Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection. PLoS Negl Trop Dis (2012) 1.51
Structural basis for differential neutralization of ebolaviruses. Viruses (2012) 1.15
Two-mAb cocktail protects macaques against the Makona variant of Ebola virus. Sci Transl Med (2016) 0.91